Liquidia Announces Poster Presentations at the 7th World Symposia on Pulmonary Hypertension (WSPH)

June 18, 2024

https://www.globenewswire.com/news-release/2024/06/18/2900414/0/en/Liquidia-Announces-Poster-Presentations-at-the-7th-World-Symposia-on-Pulmonary-Hypertension-WSPH.html

MORRISVILLE, N.C., June 18, 2024 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ:LQDA) announced today the company will present seven posters related to its product pipeline at the 7th World Symposia of Pulmonary Hypertension (WSPH) taking place June 29 to July 1, 2024, in Barcelona, Spain. The posters outlined below address the clinical investigations of Liquidia’s investigational products, YUTREPIA™ (treprostinil) inhalation powder and L606 (liposomal treprostinil) inhalation suspension sustained-release formulation to treat people with pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.